Globeflex Capital’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-218,007
Closed -$2.83M 436
2025
Q1
$2.83M Hold
218,007
0.26% 87
2024
Q4
$2.78M Hold
218,007
0.24% 101
2024
Q3
$2.43M Hold
218,007
0.23% 99
2024
Q2
$2.45M Sell
218,007
-53,880
-20% -$627K 0.26% 90
2024
Q1
$3.37M Sell
271,887
-19,464
-7% -$254K 0.33% 71
2023
Q4
$4.07M Hold
291,351
0.42% 60
2023
Q3
$4.3M Sell
291,351
-6,614
-2% -$93K 0.5% 53
2023
Q2
$3.85M Sell
297,965
-9,111
-3% -$104K 0.43% 68
2023
Q1
$3.01M Hold
307,076
0.37% 79
2022
Q4
$3.27M Buy
307,076
+49,067
+19% +$570K 0.41% 66
2022
Q3
$2.69M Buy
258,009
+238,738
+1,239% +$3.11M 0.46% 56
2022
Q2
$243K Hold
19,271
0.06% 307
2022
Q1
$209K Hold
19,271
0.04% 340
2021
Q4
$271K Hold
19,271
0.06% 333
2021
Q3
$370K Buy
+19,271
New +$256K 0.08% 263

Other funds holding DVAX

Globeflex Capital's DVAX Position: Q2 2025 in Review

Globeflex Capital sold out of Dynavax Technologies (DVAX) in Q2 2025, closing a stake of 218,007 shares — an estimated $2.83M sold.

Globeflex Capital first reported a position in DVAX in Q3 2021 and held it in 15 quarters. The position peaked at $4.3M in Q3 2023. 268 funds tracked by Wall St. Rank hold DVAX as of Q2 2025.

  • Globeflex Capital reported no remaining Dynavax Technologies position as of Q2 2025 after selling out during the quarter.
  • Globeflex Capital sold 218,007 Dynavax Technologies shares in Q2 2025, an estimated $2.83M.
  • Globeflex Capital first reported a position in Dynavax Technologies in Q3 2021 and held it in 15 quarters.
  • Globeflex Capital's Dynavax Technologies position peaked at $4.3M in Q3 2023.
  • 268 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2025.

Based on Globeflex Capital's 13F filing for Q2 2025, filed 14 Aug 2025.